This Expensive Tech Stock Could Still Rally If Growth Holds
High-priced tech names can deliver big gains if growth sticks. This article breaks down how to evaluate the momentum,...
Using Index Level to adjust risk lets you scale exposure in line with market momentum, maintaining a balanced, rules-based approach.
27,393 articlesHigh-priced tech names can deliver big gains if growth sticks. This article breaks down how to evaluate the momentum,...
When opportunities wobble, money follows. This piece breaks down how public perception, gigs, and branding affect inc...
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
A celebrity crisis can hit finances in surprising ways. This hypothetical look at the 44-year-old superstar britney s...
A record-sized end-of-quarter options expiry is set to roll across Bitcoin and Ethereum, potentially stirring markets...
A major fund slashed its stake in Papa John's, triggering questions about the stock's outlook. This guide explains wh...
Kinsale Capital has faced headwinds, but the core business still shows quality underwriting. Here’s why I’m staying i...
Investors are weighing the latest earnings from D-Wave Quantum. While losses persisted, revenue beat expectations in ...
As policy changes from lenders and the GSEs take shape, mortgage markets face a potential major shift in credit alloc...
As the first half 2026 over wraps up, AI stocks show a rotating leadership. This article highlights two compelling be...
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...